SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,152.86 -417.49
( -0.55%)

Global Indices

Nasdaq

53,087.25 299.37
(0.57%)

Dow Jones

7,688.45 35.98
(0.47%)

Hang Seng

64,337.38 11.74
(0.02%)

Nikkei 225

10,831.87 75.42
(0.70%)

Forex

USD-INR

94.95 -0.29
(-0.30%)

EUR-INR

110.11 -0.38
(-0.35%)

GBP-INR

128.48 -0.52
(-0.40%)

JPY-INR

0.59 0.00
(-0.47%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524804

INE406A01037

394.8213477

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AUROPHARMA

36.57

95299.84

EPS(TTM)

Face Value()

Div & Yield %

45.29

0.24

Back

Sandur Manganese & Iron Ores consolidated net profit rises 36.28% in the June 2026 quarter

Aug 07,2026

Net profit of Sandur Manganese & Iron Ores rose 36.28% to Rs 227.09 crore in the quarter ended June 2026 as against Rs 166.63 crore during the previous quarter ended June 2025. Sales rose 21.09% to Rs 1374.78 crore in the quarter ended June 2026 as against Rs 1135.38 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1374.78	1135.38	21
OPM %	24.99	26.36	-
PBDT	332.12	260.52	27
PBT	281.07	209.36	34
NP	227.09	166.63	36

76,152.86 -417.49 ( -0.55%)

53,087.25 299.37 (0.57%)

7,688.45 35.98 (0.47%)

64,337.38 11.74 (0.02%)

10,831.87 75.42 (0.70%)

94.95 -0.29 (-0.30%)

110.11 -0.38 (-0.35%)

128.48 -0.52 (-0.40%)

0.59 0.00 (-0.47%)